Long-Term Outcomes for Patients Treated for Hypercortisolism
The panel concludes by discussing the long-term outcomes for patients treated for hypercortisolism, emphasizing the need for further studies and data, and sharing their final thoughts on the disease and its future management.
EP: 1.Defining Resistant Diabetes
EP: 2.Differentiating Medication Non-Adherence From Underlying Comorbidities
EP: 3.Barriers to Accessing New Anti-Diabetes Medications
EP: 4.Suspecting Hypercortisolism in Patients With Resistant Diabetes
EP: 5.Testing for Hypercortisolism
EP: 6.Patient Subgroups With a Higher Prevalence of Hypercortisolism
EP: 7.Evolving Perception of Autonomous Adrenal Hypercortisolism
EP: 8.Pathophysiology of Hypercortisolism
EP: 9.Need to Address Underlying Hypercortisolism
EP: 10.Approaching Treatment in Hypercortisolism
EP: 11.Choosing Between Medical and Surgical Options for Hypercortisolism
Now Viewing
EP: 12.Long-Term Outcomes for Patients Treated for Hypercortisolism
Recent Videos
Related Content
